Eli Lilly and Company and Boehringer Ingelheim announced a new collaboration on a Phase 1b study that will evaluate the...
Read moreSanofi announced the presentation of the results of the pivotal Phase 3 LixiLan-O and LixiLan-L clinical trials with the...
Read moreBiogen reported top-line results from the Phase 2 SYNERGY study evaluating opicinumab (anti-LINGO-1), an investigational, fully human monoclonal antibody being...
Read moreAlexion Pharmaceuticals, Inc announced topline results from the REGAIN study, a Phase 3 registration trial of eculizumab (Soliris®) in patients...
Read moreBardoxolone Methyl (RTA 402) Data Show Improvement in Renal Function by Inulin Clearance in a Phase II Clinical Study in...
Read moreSubjects received one-time administration of a highly optimized gene therapy at initial low dose without the need for immunosuppression Therapeutic...
Read moreChugai Pharmaceutical Co Ltd announced that the results of the Japanese phase III study (J-ALEX) of Alecensa®, in ALK fusion...
Read moreAstraZeneca announced that benralizumab, a potential new medicine and anti-eosinophil monoclonal antibody, was well tolerated and achieved the primary endpoint...
Read moreMallinckrodt plc a leading global specialty biopharmaceutical company, today confirmed enrollment of the first patient in the company's Phase 4...
Read moreAstraZeneca announced that benralizumab, a potential new medicine and anti-eosinophil monoclonal antibody, was well tolerated and achieved the primary endpoint...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
